Myositis and myasthenia gravis autoantibody detection kit and method in human body fluid
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHAANXI MYBIOTECH CO LTD
- Publication Date
- 2022-03-04
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine, and in particular relates to a detection kit and method for myositis and myasthenia gravis autoantibodies in human body fluid. Background technique
[0002] Idiopathic inflammatory myopathies (IIMs) are rare autoimmune diseases characterized by muscle inflammation leading to proximal muscle atrophy and disability, various skin rashes, ulcers, malignancies, etc. symptom. Autoantibodies can be detected in body fluids of more than 50% of IIM patients, so autoimmunity is considered to play an important role in the pathogenesis of myositis. Current studies have shown that these autoantibodies target nuclear and cytoplasmic proteins, and they are usually divided into two subgroups, myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (Myositis-associated autoantibodies, MAAs). A large number of clinically relevant studies have shown that MSAs and MAAs are important mark...